Growth hormone-releasing peptide-biotin conjugate stimulates myocytes differentiation through insulin-like growth factor-1 and collagen type I

  • Lim, Chae Jin ;
  • Jeon, Jung Eun ;
  • Jeong, Se Kyoo ;
  • Yoon, Seok Jeong ;
  • Kwon, Seon Deok ;
  • Lim, Jina ;
  • Park, Keedon ;
  • Kim, Dae Yong ;
  • Ahn, Jeong Keun ;
  • Kim, Bong-Woo
  • Received : 2014.12.04
  • Accepted : 2015.01.22
  • Published : 2015.06.30


Based on the potential beneficial effects of growth hormone releasing peptide (GHRP)-6 on muscle functions, a newly synthesized GHRP-6-biotin conjugate was tested on cultured myoblast cells. Increased expression of myogenic marker proteins was observed in GHRP-6-biotin conjugate-treated cells. Additionally, increased expression levels of insulin-like growth factor-1 and collagen type I were observed. Furthermore, GHRP-6-biotin conjugate-treated cells showed increased metabolic activity, as indicated by increased concentrations of energy metabolites, such as ATP and lactate, and increased enzymatic activity of lactate dehydrogenase and creatine kinase. Finally, binding protein analysis suggested few candidate proteins, including desmin, actin, and zinc finger protein 691 as potential targets for GHRP6-biotin conjugate action. These results suggest that the newly synthesized GHRP-6-biotin conjugate has myogenic stimulating activity through, at least in part, by stimulating collagen type I synthesis and several key proteins. Practical applications of the GHRP-6-biotin conjugate could include improving muscle condition. [BMB Reports 2015; 48(9): 501-506]


Biotin;Collagen;Growth-hormone releasing peptide;Insulin-like growth factor;Myogenesis


  1. Paulin D and Li Z (2004) Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. Exp Cell Res 301, 1-7
  2. Li Z, Mericskay M, Agbulut O et al (1997) Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol 139, 129-144
  3. Li H, Choudhary SK, Milner DJ, Munir MI, Kuisk IR and Capetanaki Y (1994) Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin. J Cell Biol 124, 827-841
  4. Lokireddy S, Wijesoma IW, Sze SK, McFarlane C, Kambadur R and Sharma M (2012) Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. Am J Physiol Cell Physiol 303, C512-529
  5. Cohen S, Zhai B, Gygi SP and Goldberg AL (2012) Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy. J Cell Biol 198, 575-589
  6. Hong J, Kim BW, Choo HJ et al (2014) Mitochondrial complex I deficiency enhances skeletal myogenesis but impairs insulin signaling through SIRT1 inactivation. J Biol Chem 289, 20012-20025
  7. Kim BW, Lee JW, Choo HJ et al (2010) Mitochondrial oxidative phosphorylation system is recruited to detergent-resistant lipid rafts during myogenesis. Proteomics 10, 2498-2515
  8. Asakura A, Komaki M and Rudnicki M (2001) Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68, 245-253
  9. Florini JR, Ewton DZ and Magri KA (1991) Hormones, growth factors, and myogenic differentiation. Annu Rev Physiol 53, 201-216
  10. Lee CS, Yi JS, Jung SY et al (2010) TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1. Cell Death Differ 17, 1254-1265
  11. Frago LM, Paneda C, Dickson SL, Hewson AK, Argente J and Chowen JA (2002) Growth hormone (GH) and GH-re- leasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 143, 4113-4122
  12. Frago LM, Paneda C, Argente J and Chowen JA (2005) Growth hormone-releasing peptide-6 increases insulinlike growth factor-I mRNA levels and activates Akt in RCA-6 cells as a model of neuropeptide Y neurones. J Neuroendocrinol 17, 701-710
  13. Zhou S, Salisbury J, Preedy VR and Emery PW (2013) Increased collagen synthesis rate during wound healing in muscle. PLoS One 8, e58324
  14. Bonaldo P, Braghetta P, Zanetti M, Piccolo S, Volpin D and Bressan GM (1998) Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum Mol Genet 7, 2135-2140
  15. Takano H, Komuro I, Oka T et al (1998) The Rho family G proteins play a critical role in muscle differentiation. Mol Cell Biol 18, 1580-1589
  16. Schwander M, Leu M, Stumm M et al (2003) Beta1 integrins regulate myoblast fusion and sarcomere assembly. Dev Cell 4, 673-685
  17. Yi JS, Park JS, Ham YM et al (2013) MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun 4, 2354
  18. Paneda C, Arroba AI, Frago LM et al (2003) Growth hormone-releasing peptide-6 inhibits cerebellar cell death in aged rats. Neuroreport 14, 1633-1635
  19. Smith RG (2005) Development of growth hormone secretagogues. Endocr Rev 26, 346-360
  20. Granado M, Garcia-Caceres C, Tuda M, Frago LM, Chowen JA and Argente J (2011) Insulin and growth hormone-releasing peptide-6 (GHRP-6) have differential beneficial effects on cell turnover in the pituitary, hypothalamus and cerebellum of streptozotocin (STZ)-induced diabetic rats. Mol Cell Endocrinol 337, 101-113
  21. Berlanga J, Cibrian D, Guevara L et al (2007) Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction. Clin Sci (Lond) 112, 241-250
  22. Pontiroli AE (1998) Peptide hormones: Review of current and emerging uses by nasal delivery. Adv Drug Deliv Rev 29, 81-87
  23. Fleisher D, Niemiec SM, Oh CK, Hu Z, Ramachandran C and Weiner N (1995) Topical delivery of growth hormone releasing peptide using liposomal systems: an in vitro study using hairless mouse skin. Life Sci 57, 1293-1297
  24. Charge SB and Rudnicki MA (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84, 209-238
  25. Smith CK, 2nd, Janney MJ and Allen RE (1994) Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. J Cell Physiol 159, 379-385
  26. Makrantonaki E, Schonknecht P, Hossini AM et al (2010) Skin and brain age together: The role of hormones in the ageing process. Exp Gerontol 45, 801-813
  27. Zouboulis CC and Makrantonaki E (2012) Hormonal therapy of intrinsic aging. Rejuvenation Res 15, 302-312
  28. DeVita RJ (1997) Small molecule mimetics of GHRP-6. Expert Opin Investig Drugs 6, 1839-1843
  29. Micic D, Casabiell X, Gualillo O, Pombo M, Dieguez C and Casanueva FF (1999) Growth hormone secretagogues: the clinical future. Horm Res 51 Suppl 3, 29-33
  30. Makrantonaki E, Zouboulis CC and German National Genome Research N (2007) The skin as a mirror of the aging process in the human organism--state of the art and results of the aging research in the German National Genome Research Network 2 (NGFN-2). Exp Gerontol 42, 879-886
  31. Florini JR, Ewton DZ and Coolican SA (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17, 481-517

Cited by

  1. Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects vol.11, 2017,
  2. Identification of amino acids related to catalytic function of Sulfolobus solfataricus P1 carboxylesterase by site-directed mutagenesis and molecular modeling vol.49, pp.6, 2016,